David received his BS in 2011 and MS in 2012 in Chemical Engineering from the University of Tennessee in Knoxville. He then received a PhD in Biological Engineering from the Massachusetts Institute of Technology in 2018. For his doctoral work, he developed a quantitative systems pharmacology model for drug target identification in the complement system, focusing on how to represent and mitigate significant parameter uncertainty. David interned with Pfizer in 2016, performing systems pharmacology modeling work.
I enjoy programming and biology, and putting my knowledge to use toward drug development is intellectually stimulating and meaningful.